Works matching IS 03682811 AND DT 2025 AND VI 55 AND IP 5

Results: 18
    1
    2
    3

    Multicenter, open-label, randomized, controlled study to test the utility of electronic patient-reported outcome monitoring in patients with unresectable advanced cancers or metastatic/recurrent solid tumors Open Access.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 5, p. 547, doi. 10.1093/jjco/hyaf033
    By:
    • Taira, Naruto;
    • Kiyota, Naomi;
    • Kikawa, Yuichiro;
    • Ichihara, Eiki;
    • Kato, Kyoko;
    • Kubota, Kaoru;
    • Tateishi, Ryosuke;
    • Nakata, Akinobu;
    • Nakamura, Keiichiro;
    • Narita, Yukiya;
    • Hotta, Katsuyuki;
    • Iwata, Hiroji;
    • Gemma, Akihiko;
    • Shimozuma, Kojiro;
    • Muro, Kei;
    • Iwamoto, Tetsuya;
    • Takumoto, Yuki;
    • Shiroiwa, Takeru;
    • Fukuda, Takashi;
    • Yamaguchi, Takuhiro
    Publication type:
    Article
    4

    Efficacy of radioactive hypoxia-targeting therapeutic agent <sup>64</sup>Cu-ATSM on recurrent malignant glioma: a study protocol for a phase-III, investigator-sponsored, randomized controlled trial.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 5, p. 543, doi. 10.1093/jjco/hyaf026
    By:
    • Ando, Yayoi;
    • Yanagisawa, Shunsuke;
    • Ohno, Makoto;
    • Kurihara, Hiroaki;
    • Ito, Kimiteru;
    • Ichimura, Masahiko;
    • Anjo, Kenta;
    • Inaba, Masako;
    • Nagasaka, Yukari;
    • Sadachi, Ryo;
    • Shibata, Taro;
    • Okita, Natsuko;
    • Nakamura, Kenichi;
    • Matsumoto, Hiroki;
    • Yoshii, Yukie;
    • Narita, Yoshitaka
    Publication type:
    Article
    5
    6
    7

    Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 5, p. 531, doi. 10.1093/jjco/hyaf018
    By:
    • Kikuchi, Hiroshi;
    • Osawa, Takahiro;
    • Matsushita, Yuto;
    • Kojima, Takahiro;
    • Sazuka, Tomokazu;
    • Hatakeyama, Shingo;
    • Goto, Keisuke;
    • Numakura, Kazuyuki;
    • Yamana, Kazutoshi;
    • Kandori, Shuya;
    • Ueda, Kosuke;
    • Tanaka, Hajime;
    • Kurahashi, Toshifumi;
    • Bando, Yukari;
    • Kimura, Takahiro;
    • Nishiyama, Naotaka;
    • Kato, Takuma;
    • Hara, Hiroaki;
    • Ito, Yoichi;
    • Kitamura, Hiroshi
    Publication type:
    Article
    8
    9
    10

    Liquid biopsy in lung cancer Free.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 5, p. 453, doi. 10.1093/jjco/hyaf013
    By:
    • Kitagawa, Shingo;
    • Seike, Masahiro
    Publication type:
    Article
    11
    12
    13
    14

    Impact of time to treatment initiation on the development of cachexia and clinical outcomes in lung cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 5, p. 505, doi. 10.1093/jjco/hyaf009
    By:
    • Katsushima, Utae;
    • Kurose, Satoshi;
    • Fukushima, Takuya;
    • Nakano, Jiro;
    • Ogushi, Naoya;
    • Fujii, Kazuki;
    • Nagata, Yutaro;
    • Kamisako, Keisuke;
    • Okuno, Yukiko;
    • Okazaki, Yuta;
    • Nakanishi, Kentaro;
    • Yoshida, Kiyori;
    • Ikoma, Tatsuki;
    • Takeyasu, Yuki;
    • Yamanaka, Yuta;
    • Yoshioka, Hiroshige;
    • Hase, Kimitaka;
    • Kurata, Takayasu
    Publication type:
    Article
    15

    Clinical outcomes and treatment patterns of maintenance avelumab in locally advanced or metastatic urothelial carcinoma: a multicenter collaborative study.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 5, p. 522, doi. 10.1093/jjco/hyaf008
    By:
    • Taneda, Yuki;
    • Urabe, Fumihiko;
    • Uchida, Naoki;
    • Kadena, Soshi;
    • Shibata, Ken;
    • Hashimoto, Masaki;
    • Kawano, Shota;
    • Takiguchi, Yuki;
    • Ohtsuka, Takashi;
    • Nakazono, Minoru;
    • Imai, Yu;
    • Iwatani, Kosuke;
    • Kayano, Sotaro;
    • Atsuta, Mahito;
    • Tashiro, Kojiro;
    • Murakami, Masaya;
    • Tsuzuki, Shunsuke;
    • Yamamoto, Toshihiro;
    • Yamada, Hiroki;
    • Miki, Jun
    Publication type:
    Article
    16

    Evaluation of optimal timing and therapeutic efficacy of radium-223 therapy for metastatic castration-resistant prostate cancer: a multicenter collaborative study.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 5, p. 514, doi. 10.1093/jjco/hyaf007
    By:
    • Urabe, Fumihiko;
    • Kadena, Soshi;
    • Tashiro, Kojiro;
    • Tokuoka, Kenichi;
    • Taneda, Yuki;
    • Fujiwara, Kensuke;
    • Goto, Yuma;
    • Nakano, Juria;
    • Kawano, Shota;
    • Iwamoto, Yuya;
    • Fukuokaya, Wataru;
    • Imai, Yu;
    • Iwatani, Kosuke;
    • Atsuta, Mahito;
    • Ito, Kagenori;
    • Yanagisawa, Takafumi;
    • Murakami, Masaya;
    • Tsuzuki, Shunsuke;
    • Yamamoto, Toshihiro;
    • Shimomura, Tatsuya
    Publication type:
    Article
    17
    18